OS Therapies names Frank Knuettel II CFO and Kerry Clem chief commercial officer
OS Therapies appointed Frank Knuettel II as chief financial officer and Kerry Clem as chief commercial officer, both effective September 29, 2026. Christopher P. Acevedo ceased serving as CFO and will continue to provide services in a consulting capacity. The company's accompanying October 1, 2026 press release also said most outstanding accounts payable were delayed to the second quarter of 2027, which it said gives time to align cash flow needs with anticipated cash inflows.
Key points
- Knuettel, 60, becomes CFO with a base salary of $300,000 per year, rising to $360,000 after a material transaction, and an initial grant of options on 750,000 shares and 250,000 RSUs.
- Clem, 57, becomes CCO with a base salary of $300,000 per year and options on 700,000 shares plus 200,000 RSUs, subject to board approval.
- Acevedo ceased serving as CFO in connection with Knuettel's appointment and will continue as a consultant.
- The press release said the company received over $3 million in VAT refunds to date and that most outstanding accounts payable were delayed to the second quarter of 2027.
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.